D
QIAGEN N.V.
QGEN
$39.48
$0.581.49%
D
Sell
2/26/2025Downgrade
QIAGEN N.V. (QGEN) was downgraded to D+ from C- on 2/26/2025 due to a decline in the total return index.
QIAGEN N.V. (QGEN) was downgraded to D+ from C- on 2/26/2025 due to a decline in the total return index.
C
Hold
12/12/2024Upgraded
QIAGEN N.V. (QGEN) was upgraded to C- from D+ on 12/12/2024 due to an increase in the total return index, growth index and valuation index. EBIT increased 180.71% from -$160.36M to $129.43M, earnings per share increased from -$0.83 to $0.44, and operating cash flow increased 9.44% from $166.62M to $182.35M.
QIAGEN N.V. (QGEN) was upgraded to C- from D+ on 12/12/2024 due to an increase in the total return index, growth index and valuation index. EBIT increased 180.71% from -$160.36M to $129.43M, earnings per share increased from -$0.83 to $0.44, and operating cash flow increased 9.44% from $166.62M to $182.35M.
D
Sell
8/2/2024Downgrade
QIAGEN N.V. (QGEN) was downgraded to D+ from C on 8/2/2024 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.36 to -$0.83, net income declined 327.41% from $80.67M to -$183.46M, and EBIT declined 263.22% from $98.25M to -$160.36M.
QIAGEN N.V. (QGEN) was downgraded to D+ from C on 8/2/2024 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.36 to -$0.83, net income declined 327.41% from $80.67M to -$183.46M, and EBIT declined 263.22% from $98.25M to -$160.36M.
C
Hold
7/16/2024Upgraded
QIAGEN N.V. (QGEN) was upgraded to C from C- on 7/16/2024 due to an increase in the valuation index and volatility index.
QIAGEN N.V. (QGEN) was upgraded to C from C- on 7/16/2024 due to an increase in the valuation index and volatility index.
C
Hold
6/14/2024Downgrade
QIAGEN N.V. (QGEN) was downgraded to C- from C on 6/14/2024 due to a noticeable decline in the growth index, valuation index and solvency index. EBIT declined 19.13% from $121.49M to $98.25M, earnings per share declined from $0.433 to $0.36, and the quick ratio declined from 1.44 to 1.22.
QIAGEN N.V. (QGEN) was downgraded to C- from C on 6/14/2024 due to a noticeable decline in the growth index, valuation index and solvency index. EBIT declined 19.13% from $121.49M to $98.25M, earnings per share declined from $0.433 to $0.36, and the quick ratio declined from 1.44 to 1.22.
C
Hold
2/20/2024Upgraded
QIAGEN N.V. (QGEN) was upgraded to C from C- on 2/20/2024 due to an increase in the volatility index, total return index and valuation index.
QIAGEN N.V. (QGEN) was upgraded to C from C- on 2/20/2024 due to an increase in the volatility index, total return index and valuation index.
C
Hold
2/5/2024Downgrade
QIAGEN N.V. (QGEN) was downgraded to C- from C on 2/5/2024 due to a decline in the total return index and efficiency index.
QIAGEN N.V. (QGEN) was downgraded to C- from C on 2/5/2024 due to a decline in the total return index and efficiency index.
C
Hold
1/19/2024Upgraded
QIAGEN N.V. (QGEN) was upgraded to C from C- on 1/19/2024 due to an increase in the solvency index and volatility index. The quick ratio increased from 1.71 to 2.6, and debt to equity declined from 0.54 to 0.41.
QIAGEN N.V. (QGEN) was upgraded to C from C- on 1/19/2024 due to an increase in the solvency index and volatility index. The quick ratio increased from 1.71 to 2.6, and debt to equity declined from 0.54 to 0.41.
C
Hold
9/19/2023Downgrade
QIAGEN N.V. (QGEN) was downgraded to C- from C on 9/19/2023 due to a large decline in the volatility index, total return index and growth index. Earnings per share declined from $0.37 to $0.35.
QIAGEN N.V. (QGEN) was downgraded to C- from C on 9/19/2023 due to a large decline in the volatility index, total return index and growth index. Earnings per share declined from $0.37 to $0.35.
C
Hold
4/24/2023Downgrade
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 4/24/2023 due to a decline in the volatility index and total return index.
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 4/24/2023 due to a decline in the volatility index and total return index.
C
Hold
4/12/2023Downgrade
QIAGEN N.V. (QGEN) was downgraded to C+ from B- on 4/12/2023 due to a decline in the volatility index.
QIAGEN N.V. (QGEN) was downgraded to C+ from B- on 4/12/2023 due to a decline in the volatility index.
B
Buy
3/16/2023Upgraded
QIAGEN N.V. (QGEN) was upgraded to B- from C+ on 3/16/2023 due to an increase in the solvency index and volatility index. The quick ratio increased from 1.48 to 1.87, and debt to equity declined from 0.69 to 0.55.
QIAGEN N.V. (QGEN) was upgraded to B- from C+ on 3/16/2023 due to an increase in the solvency index and volatility index. The quick ratio increased from 1.48 to 1.87, and debt to equity declined from 0.69 to 0.55.
C
Hold
3/6/2023Downgrade
QIAGEN N.V. (QGEN) was downgraded to C+ from B- on 3/6/2023 due to a decline in the total return index.
QIAGEN N.V. (QGEN) was downgraded to C+ from B- on 3/6/2023 due to a decline in the total return index.
B
Buy
1/19/2023Upgraded
QIAGEN N.V. (QGEN) was upgraded to B- from C+ on 1/19/2023 due to an increase in the volatility index and total return index.
QIAGEN N.V. (QGEN) was upgraded to B- from C+ on 1/19/2023 due to an increase in the volatility index and total return index.
C
Hold
12/30/2022Upgraded
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 12/30/2022 due to an increase in the growth index and volatility index. Operating cash flow increased 23.05% from $171.95M to $211.58M.
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 12/30/2022 due to an increase in the growth index and volatility index. Operating cash flow increased 23.05% from $171.95M to $211.58M.
C
Hold
9/12/2022Downgrade
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 9/12/2022 due to a substantial decline in the growth index, solvency index and total return index. EBIT declined 40.37% from $212.82M to $126.91M, earnings per share declined from $0.67 to $0.42, and total revenue declined 17.96% from $628.39M to $515.51M.
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 9/12/2022 due to a substantial decline in the growth index, solvency index and total return index. EBIT declined 40.37% from $212.82M to $126.91M, earnings per share declined from $0.67 to $0.42, and total revenue declined 17.96% from $628.39M to $515.51M.
C
Hold
7/21/2022Upgraded
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 7/21/2022 due to an increase in the volatility index and total return index.
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 7/21/2022 due to an increase in the volatility index and total return index.
C
Hold
6/1/2022Downgrade
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 6/1/2022 due to a decline in the volatility index and total return index.
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 6/1/2022 due to a decline in the volatility index and total return index.
C
Hold
4/21/2022Downgrade
QIAGEN N.V. (QGEN) was downgraded to C+ from B- on 4/21/2022 due to a decline in the volatility index, valuation index and total return index.
QIAGEN N.V. (QGEN) was downgraded to C+ from B- on 4/21/2022 due to a decline in the volatility index, valuation index and total return index.
B
Buy
3/4/2022Downgrade
QIAGEN N.V. (QGEN) was downgraded to B- from B on 3/4/2022 due to a decline in the total return index and solvency index. The quick ratio declined from 2.53 to 1.24.
QIAGEN N.V. (QGEN) was downgraded to B- from B on 3/4/2022 due to a decline in the total return index and solvency index. The quick ratio declined from 2.53 to 1.24.
B
Buy
8/19/2021Upgraded
QIAGEN N.V. (QGEN) was upgraded to B from B- on 8/19/2021 due to a large increase in the valuation index, solvency index and efficiency index. The quick ratio increased from 2.35 to 2.53, debt to equity declined from 0.68 to 0.66, and total capital increased 2.94% from $4.79B to $4.93B.
QIAGEN N.V. (QGEN) was upgraded to B from B- on 8/19/2021 due to a large increase in the valuation index, solvency index and efficiency index. The quick ratio increased from 2.35 to 2.53, debt to equity declined from 0.68 to 0.66, and total capital increased 2.94% from $4.79B to $4.93B.
B
Buy
4/1/2021Downgrade
QIAGEN N.V. (QGEN) was downgraded to B- from B on 4/1/2021 due to a decline in the total return index and valuation index.
QIAGEN N.V. (QGEN) was downgraded to B- from B on 4/1/2021 due to a decline in the total return index and valuation index.
B
Buy
3/17/2021Upgraded
QIAGEN N.V. (QGEN) was upgraded to B from B- on 3/17/2021 due to an increase in the total return index and valuation index.
QIAGEN N.V. (QGEN) was upgraded to B from B- on 3/17/2021 due to an increase in the total return index and valuation index.
B
Buy
3/5/2021Upgraded
QIAGEN N.V. (QGEN) was upgraded to B- from C on 3/5/2021 due to a significant increase in the growth index, valuation index and efficiency index. Earnings per share increased from $0.07 to $0.8982, net income increased 1,157.75% from $16.91M to $212.69M, and operating cash flow increased 1,128.92% from $21.95M to $269.71M.
QIAGEN N.V. (QGEN) was upgraded to B- from C on 3/5/2021 due to a significant increase in the growth index, valuation index and efficiency index. Earnings per share increased from $0.07 to $0.8982, net income increased 1,157.75% from $16.91M to $212.69M, and operating cash flow increased 1,128.92% from $21.95M to $269.71M.
C
Hold
11/9/2020Upgraded
QIAGEN N.V. (QGEN) was upgraded to C from C- on 11/9/2020 due to a large increase in the efficiency index, growth index and total return index. Total capital increased 9.51% from $4.11B to $4.5B, and total revenue increased 9.14% from $443.25M to $483.76M.
QIAGEN N.V. (QGEN) was upgraded to C from C- on 11/9/2020 due to a large increase in the efficiency index, growth index and total return index. Total capital increased 9.51% from $4.11B to $4.5B, and total revenue increased 9.14% from $443.25M to $483.76M.
C
Hold
9/18/2020Downgrade
QIAGEN N.V. (QGEN) was downgraded to C- from C on 9/18/2020 due to a decline in the total return index and valuation index.
QIAGEN N.V. (QGEN) was downgraded to C- from C on 9/18/2020 due to a decline in the total return index and valuation index.
C
Hold
8/6/2020Upgraded
QIAGEN N.V. (QGEN) was upgraded to C from C- on 8/6/2020 due to a noticeable increase in the growth index, total return index and efficiency index. Operating cash flow increased 746.36% from $15.91M to $134.68M, net income increased 125.37% from $39.83M to $89.76M, and earnings per share increased from $0.17 to $0.38.
QIAGEN N.V. (QGEN) was upgraded to C from C- on 8/6/2020 due to a noticeable increase in the growth index, total return index and efficiency index. Operating cash flow increased 746.36% from $15.91M to $134.68M, net income increased 125.37% from $39.83M to $89.76M, and earnings per share increased from $0.17 to $0.38.
C
Hold
5/27/2020Upgraded
QIAGEN N.V. (QGEN) was upgraded to C- from D+ on 5/27/2020 due to a noticeable increase in the total return index.
QIAGEN N.V. (QGEN) was upgraded to C- from D+ on 5/27/2020 due to a noticeable increase in the total return index.
D
Sell
5/8/2020Downgrade
QIAGEN N.V. (QGEN) was downgraded to D+ from C- on 5/8/2020 due to a noticeable decline in the growth index, solvency index and valuation index. Operating cash flow declined 85.46% from $109.43M to $15.91M, EBIT declined 28.19% from $97.89M to $70.29M, and earnings per share declined from $0.1942 to $0.17.
QIAGEN N.V. (QGEN) was downgraded to D+ from C- on 5/8/2020 due to a noticeable decline in the growth index, solvency index and valuation index. Operating cash flow declined 85.46% from $109.43M to $15.91M, EBIT declined 28.19% from $97.89M to $70.29M, and earnings per share declined from $0.1942 to $0.17.
C
Hold
5/5/2020Upgraded
QIAGEN N.V. (QGEN) was upgraded to C- from D+ on 5/5/2020 due to an increase in the solvency index, total return index and efficiency index.
QIAGEN N.V. (QGEN) was upgraded to C- from D+ on 5/5/2020 due to an increase in the solvency index, total return index and efficiency index.
D
Sell
3/27/2020Downgrade
QIAGEN N.V. (QGEN) was downgraded to D+ from C- on 3/27/2020 due to a decline in the total return index and solvency index.
QIAGEN N.V. (QGEN) was downgraded to D+ from C- on 3/27/2020 due to a decline in the total return index and solvency index.
C
Hold
3/4/2020Upgraded
QIAGEN N.V. (QGEN) was upgraded to C- from D+ on 3/4/2020 due to a noticeable increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.71 to $0.1942, EBIT increased 75.62% from $55.74M to $97.89M, and operating cash flow increased 16.17% from $94.2M to $109.43M.
QIAGEN N.V. (QGEN) was upgraded to C- from D+ on 3/4/2020 due to a noticeable increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.71 to $0.1942, EBIT increased 75.62% from $55.74M to $97.89M, and operating cash flow increased 16.17% from $94.2M to $109.43M.
D
Sell
11/20/2019Upgraded
QIAGEN N.V. (QGEN) was upgraded to D+ from D on 11/20/2019 due to an increase in the volatility index and total return index.
QIAGEN N.V. (QGEN) was upgraded to D+ from D on 11/20/2019 due to an increase in the volatility index and total return index.
D
Sell
11/5/2019Downgrade
QIAGEN N.V. (QGEN) was downgraded to D from C on 11/5/2019 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.19 to -$0.71, net income declined 459.14% from $44.73M to -$160.64M, and total capital declined 4.01% from $4.47B to $4.29B.
QIAGEN N.V. (QGEN) was downgraded to D from C on 11/5/2019 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.19 to -$0.71, net income declined 459.14% from $44.73M to -$160.64M, and total capital declined 4.01% from $4.47B to $4.29B.
C
Hold
10/14/2019Downgrade
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 10/14/2019 due to a decline in the volatility index and total return index.
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 10/14/2019 due to a decline in the volatility index and total return index.
C
Hold
10/8/2019Downgrade
QIAGEN N.V. (QGEN) was downgraded to C+ from B- on 10/8/2019 due to a major decline in the volatility index and total return index.
QIAGEN N.V. (QGEN) was downgraded to C+ from B- on 10/8/2019 due to a major decline in the volatility index and total return index.
B
Buy
9/26/2019Downgrade
QIAGEN N.V. (QGEN) was downgraded to B- from B on 9/26/2019 due to a decline in the total return index and volatility index.
QIAGEN N.V. (QGEN) was downgraded to B- from B on 9/26/2019 due to a decline in the total return index and volatility index.
B
Buy
8/7/2019Upgraded
QIAGEN N.V. (QGEN) was upgraded to B from B- on 8/7/2019 due to an increase in the growth index, solvency index and valuation index. Operating cash flow increased 84.38% from $44.73M to $82.48M, earnings per share increased from $0.13 to $0.19, and total revenue increased 9.45% from $348.65M to $381.61M.
QIAGEN N.V. (QGEN) was upgraded to B from B- on 8/7/2019 due to an increase in the growth index, solvency index and valuation index. Operating cash flow increased 84.38% from $44.73M to $82.48M, earnings per share increased from $0.13 to $0.19, and total revenue increased 9.45% from $348.65M to $381.61M.
B
Buy
5/15/2019Downgrade
QIAGEN N.V. (QGEN) was downgraded to B- from B on 5/15/2019 due to a noticeable decline in the growth index, total return index and solvency index. Operating cash flow declined 59.52% from $110.51M to $44.73M, EBIT declined 53.81% from $108.67M to $50.19M, and earnings per share declined from $0.2623 to $0.13.
QIAGEN N.V. (QGEN) was downgraded to B- from B on 5/15/2019 due to a noticeable decline in the growth index, total return index and solvency index. Operating cash flow declined 59.52% from $110.51M to $44.73M, EBIT declined 53.81% from $108.67M to $50.19M, and earnings per share declined from $0.2623 to $0.13.
B
Buy
3/12/2019Upgraded
QIAGEN N.V. (QGEN) was upgraded to B from C+ on 3/12/2019 due to a major increase in the growth index, valuation index and total return index. EBIT increased 40.34% from $77.43M to $108.67M, operating cash flow increased 33.55% from $82.75M to $110.51M, and total revenue increased 6.68% from $377.91M to $403.17M.
QIAGEN N.V. (QGEN) was upgraded to B from C+ on 3/12/2019 due to a major increase in the growth index, valuation index and total return index. EBIT increased 40.34% from $77.43M to $108.67M, operating cash flow increased 33.55% from $82.75M to $110.51M, and total revenue increased 6.68% from $377.91M to $403.17M.
C
Hold
2/25/2019Upgraded
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 2/25/2019 due to an increase in the volatility index.
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 2/25/2019 due to an increase in the volatility index.
C
Hold
12/10/2018Downgrade
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 12/10/2018 due to a noticeable decline in the total return index, growth index and solvency index. Operating cash flow declined 29.89% from $118.02M to $82.75M, and the quick ratio declined from 1.34 to 0.94.
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 12/10/2018 due to a noticeable decline in the total return index, growth index and solvency index. Operating cash flow declined 29.89% from $118.02M to $82.75M, and the quick ratio declined from 1.34 to 0.94.
C
Hold
8/27/2018Upgraded
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 8/27/2018 due to a significant increase in the growth index and volatility index. Operating cash flow increased 144.78% from $48.22M to $118.02M, EBIT increased 49.24% from $49.07M to $73.23M, and earnings per share increased from $0.14 to $0.16.
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 8/27/2018 due to a significant increase in the growth index and volatility index. Operating cash flow increased 144.78% from $48.22M to $118.02M, EBIT increased 49.24% from $49.07M to $73.23M, and earnings per share increased from $0.14 to $0.16.
C
Hold
8/2/2017Downgrade
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 8/2/2017 due to a significant decline in the growth index, volatility index and efficiency index. Earnings per share declined from $0.0768 to $0.06, net income declined 20.96% from $17.65M to $13.95M, and EBIT declined 12.78% from $32.75M to $28.57M.
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 8/2/2017 due to a significant decline in the growth index, volatility index and efficiency index. Earnings per share declined from $0.0768 to $0.06, net income declined 20.96% from $17.65M to $13.95M, and EBIT declined 12.78% from $32.75M to $28.57M.
C
Hold
5/10/2017Upgraded
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 5/10/2017 due to a major increase in the growth index, total return index and efficiency index. Earnings per share increased from $0.0466 to $0.0768, and net income increased 64.07% from $10.76M to $17.65M.
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 5/10/2017 due to a major increase in the growth index, total return index and efficiency index. Earnings per share increased from $0.0466 to $0.0768, and net income increased 64.07% from $10.76M to $17.65M.
C
Hold
4/7/2017Downgrade
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 4/7/2017 due to a decline in the total return index and volatility index.
QIAGEN N.V. (QGEN) was downgraded to C from C+ on 4/7/2017 due to a decline in the total return index and volatility index.
C
Hold
3/23/2017Upgraded
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 3/23/2017 due to an increase in the total return index, volatility index and solvency index.
QIAGEN N.V. (QGEN) was upgraded to C+ from C on 3/23/2017 due to an increase in the total return index, volatility index and solvency index.
C
Hold
3/8/2017Downgrade
QIAGEN N.V. (QGEN) was downgraded to C from B- on 3/8/2017 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 68.13% from $33.76M to $10.76M, earnings per share declined from $0.1454 to $0.0466, and total capital declined 1.77% from $3.74B to $3.68B.
QIAGEN N.V. (QGEN) was downgraded to C from B- on 3/8/2017 due to a significant decline in the growth index, valuation index and efficiency index. Net income declined 68.13% from $33.76M to $10.76M, earnings per share declined from $0.1454 to $0.0466, and total capital declined 1.77% from $3.74B to $3.68B.
B
Buy
10/13/2016Upgraded
Qiagen NV (QGEN) was upgraded to B- from C+ on 10/13/2016 due to an increase in the total return index and volatility index.
Qiagen NV (QGEN) was upgraded to B- from C+ on 10/13/2016 due to an increase in the total return index and volatility index.
C
Hold
8/16/2016Upgraded
Qiagen NV (QGEN) was upgraded to C+ from C on 8/16/2016 due to a significant increase in the growth index, volatility index and efficiency index. EBIT increased 130.06% from $13.9M to $31.98M, operating cash flow increased 103.48% from $48.69M to $99.08M, and earnings per share increased from $0.06 to $0.0895.
Qiagen NV (QGEN) was upgraded to C+ from C on 8/16/2016 due to a significant increase in the growth index, volatility index and efficiency index. EBIT increased 130.06% from $13.9M to $31.98M, operating cash flow increased 103.48% from $48.69M to $99.08M, and earnings per share increased from $0.06 to $0.0895.
C
Hold
6/29/2016Upgraded
Qiagen NV (QGEN) was upgraded to C from C- on 6/29/2016 due to an increase in the volatility index and valuation index.
Qiagen NV (QGEN) was upgraded to C from C- on 6/29/2016 due to an increase in the volatility index and valuation index.
C
Hold
6/14/2016Downgrade
Qiagen NV (QGEN) was downgraded to C- from C on 6/14/2016 due to a decline in the valuation index and volatility index.
Qiagen NV (QGEN) was downgraded to C- from C on 6/14/2016 due to a decline in the valuation index and volatility index.
C
Hold
5/25/2016Upgraded
Qiagen NV (QGEN) was upgraded to C from C- on 5/25/2016 due to an increase in the valuation index, total return index and volatility index.
Qiagen NV (QGEN) was upgraded to C from C- on 5/25/2016 due to an increase in the valuation index, total return index and volatility index.
C
Hold
4/29/2016Downgrade
Qiagen NV (QGEN) was downgraded to C- from C on 4/29/2016 due to a significant decline in the growth index, total return index and volatility index. EBIT declined 76.75% from $59.78M to $13.9M, earnings per share declined from $0.2048 to $0.06, and operating cash flow declined 43.88% from $86.76M to $48.69M.
Qiagen NV (QGEN) was downgraded to C- from C on 4/29/2016 due to a significant decline in the growth index, total return index and volatility index. EBIT declined 76.75% from $59.78M to $13.9M, earnings per share declined from $0.2048 to $0.06, and operating cash flow declined 43.88% from $86.76M to $48.69M.
C
Hold
3/11/2016Downgrade
Qiagen NV (QGEN) was downgraded to C from C+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
Qiagen NV (QGEN) was downgraded to C from C+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
C
Hold
11/19/2015Downgrade
Qiagen NV (QGEN) was downgraded to C+ from B- on 11/19/2015 due to a decline in the growth index, volatility index and total return index. Total revenue declined 1.53% from $319.46M to $314.56M.
Qiagen NV (QGEN) was downgraded to C+ from B- on 11/19/2015 due to a decline in the growth index, volatility index and total return index. Total revenue declined 1.53% from $319.46M to $314.56M.
B
Buy
7/31/2015Downgrade
Qiagen NV (QGEN) was downgraded to B- from B on 7/31/2015 due to a large decline in the valuation index and efficiency index.
Qiagen NV (QGEN) was downgraded to B- from B on 7/31/2015 due to a large decline in the valuation index and efficiency index.
B
Buy
7/13/2015Upgraded
Qiagen NV (QGEN) was upgraded to B from B- on 7/13/2015 due to an increase in the volatility index.
Qiagen NV (QGEN) was upgraded to B from B- on 7/13/2015 due to an increase in the volatility index.
B
Buy
6/11/2015Downgrade
Qiagen NV (QGEN) was downgraded to B- from B on 6/11/2015 due to a decline in the total return index and volatility index.
Qiagen NV (QGEN) was downgraded to B- from B on 6/11/2015 due to a decline in the total return index and volatility index.
B
Buy
5/27/2015Upgraded
Qiagen NV (QGEN) was upgraded to B from B- on 5/27/2015 due to an increase in the total return index and volatility index.
Qiagen NV (QGEN) was upgraded to B from B- on 5/27/2015 due to an increase in the total return index and volatility index.
B
Buy
5/11/2015Downgrade
Qiagen NV (QGEN) was downgraded to B- from B on 5/11/2015 due to a decline in the growth index, solvency index and valuation index. EBIT declined 39.08% from $57.67M to $35.13M, operating cash flow declined 20.47% from $79.02M to $62.84M, and earnings per share declined from $0.1 to $0.08.
Qiagen NV (QGEN) was downgraded to B- from B on 5/11/2015 due to a decline in the growth index, solvency index and valuation index. EBIT declined 39.08% from $57.67M to $35.13M, operating cash flow declined 20.47% from $79.02M to $62.84M, and earnings per share declined from $0.1 to $0.08.
B
Buy
12/31/2014Upgraded
Qiagen NV (QGEN) was upgraded to B from B- on 12/31/2014 due to an increase in the volatility index and valuation index.
Qiagen NV (QGEN) was upgraded to B from B- on 12/31/2014 due to an increase in the volatility index and valuation index.
B
Buy
12/12/2014Downgrade
Qiagen NV (QGEN) was downgraded to B- from B on 12/12/2014 due to a large decline in the volatility index, growth index and total return index.
Qiagen NV (QGEN) was downgraded to B- from B on 12/12/2014 due to a large decline in the volatility index, growth index and total return index.
B
Buy
8/1/2014Upgraded
Qiagen NV (QGEN) was upgraded to B from C on 8/1/2014 due to a significant increase in the growth index, valuation index and total return index. Operating cash flow increased 61.38% from $45.61M to $73.6M, earnings per share increased from $0.0999 to $0.14, and EBIT increased 15.75% from $41.2M to $47.69M.
Qiagen NV (QGEN) was upgraded to B from C on 8/1/2014 due to a significant increase in the growth index, valuation index and total return index. Operating cash flow increased 61.38% from $45.61M to $73.6M, earnings per share increased from $0.0999 to $0.14, and EBIT increased 15.75% from $41.2M to $47.69M.
NYSE
03/14/2025 4:00PM Eastern
Quotes delayed
